IQVIA

IQVIA Holdings, Inc. is an American company based in Durham, North Carolina, focused on health information technology and clinical research.

The company operates three divisions: Technology & Analytics (40% of 2024 revenues), focused on health information technology with access to 1.2 billion unique non-identified patient records globally, offers cloud-based customer relationship management application software as well as analytics consulting services all to the healthcare industry; Research & Development (55% of 2024 revenues), which is a contract research organization that handles all aspects of clinical trials including phase I through IV clinical trial management, clinical pharmacology, post-approval services, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, monitoring, data management and biostatistics; and Contract Sales & Medical (5% of 2024 revenues), which offers contract sales to healthcare providers and patient engagement services.[1]

The company is ranked 282nd on the Fortune 500 [2] and 680th on the Forbes Global 2000.[3]

History

IMS Health

Quintiles

Quintiles was the world's largest provider of biopharmaceutical development and commercial outsourcing services. The company offered clinical data management, clinical trial execution services, pharmaceuticals, drug development, financial partnering, and commercialization expertise to companies in the biotechnology, pharmaceutical and healthcare sectors.

In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.[7] Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990.[8] In 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.[9] In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.[10] Quintiles went public in 1997 and completed a successful secondary stock offering.[11]

In 1974, Dennis Gillings signs the first contract to provide statistical and data management consulting for pharmaceutical clients.
In 1982, Quintiles, Inc., is incorporated in North Carolina.
In 1990, Quintiles Pacific Inc. and Quintiles Ireland Ltd. are established.
In 1991, Quintiles GmbH is established in Germany; Quintiles Laboratories Ltd. is established in Atlanta, Georgia.
In 1996, Quintiles buys Innovex Ltd. and BRI International Inc., becoming the world's largest CRO.
In 1997, Quintiles goes public, completing a successful secondary stock offering.
In 1998, Quintiles becomes the first company in the industry to break the $1 billion mark, when it reports net revenues of $1.19 billion.
In 1999, the company joins the S&P 500 Index.
In 2003, the Board of Directors agrees to merge with Pharma Services Holdings Inc; Quintiles becomes a private company.
In 2009, Quintiles opens new corporate headquarters in Durham, North Carolina.
In 2010, Quintiles opens new European headquarters in the UK and establishes operations in East Africa.
In 2011, Quintiles buys Advion Biosciences, a bioanalytical lab based out of Ithaca, New York.
In 2013, Quintiles filed for an IPO on 15 February in order to go public again; Quintiles begins trading on the New York Stock Exchange (NYSE) under ticker symbol Q."

Merger of IMS Health and Quintiles

In October 2016, Quintiles merged with IMS Health to form QuintilesIMS.[5][12][13][14][15] In November 2017, the company adopted the new name of IQVIA.

type	Public
traded as	nyse: IQV S&P 500 component
foundation	1982
founder	Dennis Gillings
location	Durham, North Carolina, U.S.
key people	Ari Bousbib (Chairman & CEO)
industry	Contract Research Organization Pharmaceutical Service, AI, IT, Consulting
products	Strategy & Operation Consulting, Support services for pharmaceutical, biotech and medical companies and individuals
revenue	US$16.3 billion (2025)
operating income	US$2.18 billion (2025)
net income	US$1.36 billion (2025)
assets	US$29.9 billion (2025)
equity	US$6.63 billion (2025)
num employees	93,000
num employees year	2025
website	iqvia.com
footnotes	‡R1R‡

History

IMS Health

Quintiles

Merger of IMS Health and Quintiles

Controversies

External links

References